Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1326  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission




 
 Table of Contents  
ORIGINAL/BRIEF
Year : 2012  |  Volume : 4  |  Issue : 5  |  Page : 69-70  

Development and characterization of microemulsion containing antihypertensive agent using factorial design


Department of Pharmaceutics and Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta: Petlad, Dist: Anand, Gujarat, India

Date of Web Publication21-Mar-2012

Correspondence Address:
P Shah
Department of Pharmaceutics and Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta: Petlad, Dist: Anand, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0975-7406.94143

Rights and Permissions
   Abstract 

Microemulsion which act as a carrier for drug having poor water solubility, were formulated by the use of excipients having safety of administration and solubility of drug component. The phase study was carried out using isopropyl myristate, cremophor-el, propylene glycol and water with different ratios of components. Microemulsion region was chosen on basis of area covered. The % oil and % surfactant were selected as the independent factors and particle size and viscosity were selected as the dependent factors for the 2 2 Full Factorial Design. The optimized formulation showed the overcoming of the dissolution barrier helping in the formulation and administration.

Keywords: Full factorial design, microemulsion, phase study


How to cite this article:
Shah P, Swarnkar D, Parikh R. Development and characterization of microemulsion containing antihypertensive agent using factorial design. J Pharm Bioall Sci 2012;4, Suppl S1:69-70

How to cite this URL:
Shah P, Swarnkar D, Parikh R. Development and characterization of microemulsion containing antihypertensive agent using factorial design. J Pharm Bioall Sci [serial online] 2012 [cited 2020 Aug 9];4, Suppl S1:69-70. Available from: http://www.jpbsonline.org/text.asp?2012/4/5/69/94143

Microemulsion as a carrier has been proved to be useful, specifically for agents having poor water solubility, as O/W microemulsion. [1] Antihypertensive agent Felodipine (FLD) (Dihydro-pyridine class calcium channel blocker) is absorbed throughout the gastro-intestinal tract. FLD is having very poor water solubility (0.8 μg/ml). So, solubility is the major barrier for the formulation development. Microemulsion can be used as drug carrier in which drug is incorporated into droplet structure (size 10 nm to 200 nm), leading to dissolution rate enhancement. [2]


   Materials and Methods Top


All the ingredients of the formulation were chosen on the safety and solubility basis. The FLD was obtained as gift sample from Cipla Ltd (Mumbai). Isopropyl myristate, cremophor el, PEG 400, castor oil, tween 80, tween 20 were purchased from the Himedia Ltd. (Mumbai), and propylene glycol was purchased from Merck Inc. (Mumbai). All other ingredients were purchased of AR grade.

Ingredients were subjected to the solubility study. For this study excess of FLD was added into various components and then was subjected to the vortexing for 15 minutes and mixing for the 48 hours, after that the spectrophotometric determination was carried out. After quantification, the major components chosen were isopropyl myristate (IPM) (as Oil), cremophor-el (CEL) (as Surfactant) and propylene glycol (PG) (as Cosurfactant).

The phase study was carried out using IPM: CEL: PG: WATER with different ratios of the CEL: PG. From the phase diagram the microemulsion region was selected which had the greatest area covering the phase diagram. The 2 2 factorial design was applied for the screening of the microemulsion using the independent factors as amount of oil and surfactant and the dependent factors as particle size (PSA) and viscosity. The selected microemulsion was subjected to the various characterizations like DLS, pH, conductivity, transparency, viscosity etc. The stability of the microemulsion at room temperature, at 2°C and against centrifugal force was checked for the 1 month period.


   Results and Discussion Top


Solubility study was carried out and IPM was selected as oil (25 mg/ml). The other components chosen were CEL, PG as surfactant and cosurfactant. Phase study shows the CEL: PG (3:1) ratio as a widest microemulsion region containing composition. From the 2 2 factorial design (Design Expert 8.0.7.1, Stat-Ease Inc., Minnesota, USA) the analysis of the PSA [Figure 1] and viscosity [Figure 2] as the factorial model could be plotted as below.

Selected formulation was having 97.3nm z-average size(Malvern Zetasizer ns 90), p. 5.6 (Elico pH meter), conductivity 65 μS/ cm(EC-TDS Analyzer), transparency as % transmittance measurement which was 99.1% at 620 nm (UV 1800 Shimadzu) and viscosity was 70 cPs (Brookfield Viscometer-LVT). Microemulsion formulation showed in-vitro release up to 98% in 1 hour. Microemulsion formulation showed 5000-10000 times enhancement of solubility in comparison to the absolute solubility.
Figure 1: Contour and 3D surface plot for PSA as dependent factor

Click here to view
Figure 2: Contour and 3D surface plot for viscosity as dependent factor

Click here to view



   Conclusion Top


The formulated microemulsion succeeded in achieving the dissolution barrier of the FLD. Thus it aid in the formulation and administration of the FLD leading to improved compliance and dosage delivery.


   Acknowledgement Top


The Authors are thankful to the Cipla Ltd. (Mumbai) for the gift sample of FLD. The authors are thankful to the RPCP (CHARUSAT) for providing necessary facility for the research work.

 
   References Top

1.Kawakami K, Yoshikawa T, Moroto Y, Kanoka E, Takahashi K, Nishihara Y, Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control Release 2002, 17; 81(1-2): 65-74.  Back to cited text no. 1
    
2.Hu L., Wu H., Niu F., Yan C., Yang X., Jia Y. Design of Fenofibrate Microemulsion for improved bioavailability. Int. J. Pharm. 2011, 420(2):251-5.  Back to cited text no. 2
    


    Figures

  [Figure 1], [Figure 2]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Materials and Me...
    Results and Disc...
   Conclusion
   Acknowledgement
    References
    Article Figures

 Article Access Statistics
    Viewed1641    
    Printed80    
    Emailed0    
    PDF Downloaded122    
    Comments [Add]    

Recommend this journal